These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23651020)

  • 1. Institutional profile: University of Florida and Shands Hospital Personalized Medicine Program: clinical implementation of pharmacogenetics.
    Johnson JA; Elsey AR; Clare-Salzler MJ; Nessl D; Conlon M; Nelson DR
    Pharmacogenomics; 2013 May; 14(7):723-6. PubMed ID: 23651020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Institutional profile: University of Florida Health Personalized Medicine Program.
    Cavallari LH; Weitzel KW; Elsey AR; Liu X; Mosley SA; Smith DM; Staley BJ; Winterstein AG; Mathews CA; Franchi F; Rollini F; Angiolillo DJ; Starostik P; Clare-Salzler MJ; Nelson DR; Johnson JA
    Pharmacogenomics; 2017 Apr; 18(5):421-426. PubMed ID: 28346068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array.
    Johnson JA; Burkley BM; Langaee TY; Clare-Salzler MJ; Klein TE; Altman RB
    Clin Pharmacol Ther; 2012 Oct; 92(4):437-9. PubMed ID: 22910441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized medicine: potential, barriers and contemporary issues.
    Sorich MJ; McKinnon RA
    Curr Drug Metab; 2012 Sep; 13(7):1000-6. PubMed ID: 22591350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CLIPMERGE PGx Program: clinical implementation of personalized medicine through electronic health records and genomics-pharmacogenomics.
    Gottesman O; Scott SA; Ellis SB; Overby CL; Ludtke A; Hulot JS; Hall J; Chatani K; Myers K; Kannry JL; Bottinger EP
    Clin Pharmacol Ther; 2013 Aug; 94(2):214-7. PubMed ID: 23588317
    [No Abstract]   [Full Text] [Related]  

  • 6. Precision Medicine-Nobody Is Average.
    Vinks AA
    Clin Pharmacol Ther; 2017 Mar; 101(3):304-307. PubMed ID: 28194769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of pharmacogenetics in public health and clinical health care: a SWOT analysis.
    Kapoor R; Tan-Koi WC; Teo YY
    Eur J Hum Genet; 2016 Dec; 24(12):1651-1657. PubMed ID: 27577547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translating personalized genomic medicine into clinical practice: evidence, values, and health policy.
    Bombard Y
    Genome; 2015 Dec; 58(12):491-7. PubMed ID: 26577841
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacogenomics Implementation: Considerations for Selecting a Reference Laboratory.
    Vo TT; Bell GC; Owusu Obeng A; Hicks JK; Dunnenberger HM
    Pharmacotherapy; 2017 Sep; 37(9):1014-1022. PubMed ID: 28699700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The opportunities and challenges of implementing genomics-informed personalized medicine.
    Chisholm RL
    Clin Pharmacol Ther; 2013 Aug; 94(2):181-2. PubMed ID: 23872829
    [No Abstract]   [Full Text] [Related]  

  • 11. Prerequisites to implementing a pharmacogenomics program in a large health-care system.
    Levy KD; Decker BS; Carpenter JS; Flockhart DA; Dexter PR; Desta Z; Skaar TC
    Clin Pharmacol Ther; 2014 Sep; 96(3):307-9. PubMed ID: 24807457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment and clinical utility of pharmacogenomics by healthcare practitioners in North Carolina.
    Raccor BS; Thompson DK; Thomas C; Hill AK; Shields K; Alcala-Williams I; Cartrette T; Fasinu P; Al-Achi A
    Pharmacogenomics; 2021 Jan; 22(1):13-25. PubMed ID: 33356552
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group.
    Bank PCD; Caudle KE; Swen JJ; Gammal RS; Whirl-Carrillo M; Klein TE; Relling MV; Guchelaar HJ
    Clin Pharmacol Ther; 2018 Apr; 103(4):599-618. PubMed ID: 28994452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized medicine: hope or hype.
    Wald NJ; Morris JK
    Eur Heart J; 2012 Jul; 33(13):1553-4. PubMed ID: 22659200
    [No Abstract]   [Full Text] [Related]  

  • 15. Precision Medicine: Lessons Learned From Implementation of a Pharmacogenetics-Based Patient Care Program in a Real-World Setting.
    Kim RB
    Clin Pharmacol Ther; 2019 Nov; 106(5):933-935. PubMed ID: 31520405
    [No Abstract]   [Full Text] [Related]  

  • 16. Going to the negative: genomics for optimized medical prescription.
    Gibson G
    Nat Rev Genet; 2019 Jan; 20(1):1-2. PubMed ID: 30348998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Pharmacogenomics: achievements, challenges and prospects, for patients, pharmaceutical industries and healthcare systems".
    Sanoudou D
    Curr Pharm Des; 2010; 16(20):2182-3. PubMed ID: 20459384
    [No Abstract]   [Full Text] [Related]  

  • 18. Development to enable precision medicine in Africa.
    Mulder N
    Per Med; 2017 Nov; 14(6):467-470. PubMed ID: 29749855
    [No Abstract]   [Full Text] [Related]  

  • 19. Conference report: inaugural Pharmacogenomics Access & Reimbursement Symposium.
    Rogers SL; Patrinos GP; Mitropoulou C; Formea CM; Shawn Jones J; Brown BG
    Pharmacogenomics J; 2021 Oct; 21(5):622-624. PubMed ID: 34140646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges in Ordering and Interpreting Pharmacogenomic Tests in Clinical Practice.
    Moyer AM; Rohrer Vitek CR; Giri J; Caraballo PJ
    Am J Med; 2017 Dec; 130(12):1342-1344. PubMed ID: 28757317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.